{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:40:24Z","timestamp":1791157224159,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11899-010-0062-x","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T03:49:46Z","timestamp":1280980186000},"page":"222-228","source":"Crossref","is-referenced-by-count":33,"title":["Prognostic Markers in Peripheral T-Cell Lymphoma"],"prefix":"10.1007","volume":"5","author":[{"given":"Pier Paolo","family":"Piccaluga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mannu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,6]]},"reference":[{"issue":"5","key":"62_CR1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al.: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84(5):1361\u20131392.","journal-title":"Blood"},{"key":"62_CR2","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 1997, 89(11):3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"62_CR3","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"S Swerdlow","year":"2008","unstructured":"\u2022\u2022 Swerdlow S, Campo E, Harris NL, et al. (eds): WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, edn 4. Lyon: IARC; 2008. This is the most recent update of the WHO classification of tumors of hematopoietic and lymphoid tissues.","edition":"4"},{"key":"62_CR4","first-page":"429","volume-title":"Peripheral T-cell lymphoma, not otherwise specified. In WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"S Pileri","year":"2008","unstructured":"\u2022\u2022 Pileri S, Ralfkiaer E, Weisenburger D, et al.: Peripheral T-cell lymphoma, not otherwise specified. In WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, edn 4. Edited by Swerdlow S, Campo E, Harris NL, et al. Lyon: IARC; 2008:429. This is the original chapter on PTCL\/NOS published in the WHO Classification.","edition":"4"},{"issue":"25","key":"62_CR5","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"\u2022\u2022 Vose J, Armitage J, Weisenburger D: International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008, 26(25):4124\u20134130. In this report, the authors describe some major findings within the International Peripheral T-Cell Lymphoma Project.","journal-title":"J Clin Oncol"},{"issue":"12","key":"62_CR6","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"\u2022 Savage KJ, Harris NL, Vose JM, et al.: ALK\u2212 anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008, 111(12):5496\u20135504. In this report, the authors describe some major findings within the International Peripheral T-Cell Lymphoma Project concerning ALCL.","journal-title":"Blood"},{"issue":"4","key":"62_CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11864-004-0020-8","volume":"5","author":"AM Evens","year":"2004","unstructured":"Evens AM, Gartenhaus RB: Treatment of T-cell non-Hodgkin\u2019s lymphoma. Curr Treat Options Oncol 2004, 5(4):289\u2013303.","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"62_CR8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","volume":"9","author":"A Lopez-Guillermo","year":"1998","unstructured":"Lopez-Guillermo A, Cid J, Salar A, et al.: Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol 1998, 9(8):849\u2013855.","journal-title":"Ann Oncol"},{"issue":"1","key":"62_CR9","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, et al.: Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA). Blood 1998, 92(1):76\u201382.","journal-title":"Blood"},{"key":"62_CR10","doi-asserted-by":"crossref","unstructured":"Effect of age on the characteristics and clinical behavior of non-Hodgkin\u2019s lymphoma patients. The Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 1997, 8(10):973\u2013978.","DOI":"10.1023\/A:1008205619617"},{"issue":"16","key":"62_CR11","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, et al.: Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006, 24(16):2472\u20132479.","journal-title":"J Clin Oncol"},{"issue":"1","key":"62_CR12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR, et al.: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 2002, 13(1):140\u2013149.","journal-title":"Ann Oncol"},{"issue":"5","key":"62_CR13","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0002-9440(10)63742-X","volume":"164","author":"A Zettl","year":"2004","unstructured":"Zettl A, Rudiger T, Konrad MA, et al.: Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004, 164(5):1837\u20131848.","journal-title":"Am J Pathol"},{"issue":"11","key":"62_CR14","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1182\/blood-2005-09-3801","volume":"107","author":"A Oshiro","year":"2006","unstructured":"Oshiro A, Tagawa H, Ohshima K, et al.: Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia\/lymphoma. Blood 2006, 107(11):4500\u20134507.","journal-title":"Blood"},{"issue":"3","key":"62_CR15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2141.2009.07956.x","volume":"148","author":"S Hartmann","year":"2010","unstructured":"Hartmann S, Gesk S, Scholtysik R, et al.: High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. Br J Haematol 2010, 148(3):402\u2013412.","journal-title":"Br J Haematol"},{"issue":"6","key":"62_CR16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","volume":"8","author":"S Ascani","year":"1997","unstructured":"Ascani S, Zinzani PL, Gherlinzoni F, et al.: Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol 1997, 8(6):583\u2013592.","journal-title":"Ann Oncol"},{"issue":"3","key":"62_CR17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","volume":"117","author":"PP Piccaluga","year":"2007","unstructured":"\u2022\u2022 Piccaluga PP, Agostinelli C, Califano A, et al.: Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007, 117(3):823\u2013834. In this article, the authors presented for the first time a global GEP study in the field of PTCLs, providing new evidence on their histogenesis and pathogenesis and proposing new therapeutic targets.","journal-title":"J Clin Invest"},{"issue":"9","key":"62_CR18","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E, et al.: Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010, 28(9):1583\u20131590.","journal-title":"J Clin Oncol"},{"key":"62_CR19","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 1993, 329(14):987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"issue":"8","key":"62_CR20","first-page":"2697","volume":"93","author":"B Falini","year":"1999","unstructured":"Falini B, Pileri S, Zinzani PL, et al.: ALK+ lymphoma: clinico-pathological findings and outcome. Blood 1999, 93(8):2697\u20132706.","journal-title":"Blood"},{"issue":"4","key":"62_CR21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdn696","volume":"20","author":"J Suzumiya","year":"2009","unstructured":"\u2022 Suzumiya J, Ohshima K, Tamura K, et al.: The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia\/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. Ann Oncol 2009, 20(4):715\u2013721. This is a large study within the International Peripheral T-Cell Lymphoma Project on aggressive adult T-cell leukemia\/lymphoma.","journal-title":"Ann Oncol"},{"issue":"7","key":"62_CR22","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, et al.: Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004, 103(7):2474\u20132479.","journal-title":"Blood"},{"issue":"3","key":"62_CR23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/1097-0142(19930801)72:3<909::AID-CNCR2820720341>3.0.CO;2-O","volume":"72","author":"AL Cheng","year":"1993","unstructured":"Cheng AL, Su IJ, Chen YC, et al.: Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer 1993, 72(3):909\u2013916.","journal-title":"Cancer"},{"issue":"3","key":"62_CR24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2559.2001.01058.x","volume":"38","author":"PM Kluin","year":"2001","unstructured":"Kluin PM, Feller A, Gaulard P, et al.: Peripheral T\/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology. Histopathology 2001, 38(3):250\u2013270.","journal-title":"Histopathology"},{"issue":"13","key":"62_CR25","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","volume":"108","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Emile JF, Mounier N, et al.: Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) study. Blood 2006, 108(13):4163\u20134169.","journal-title":"Blood"},{"issue":"6","key":"62_CR26","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","volume":"102","author":"MW Bekkenk","year":"2003","unstructured":"Bekkenk MW, Vermeer MH, Jansen PM, et al.: Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood 2003, 102(6):2213\u20132219.","journal-title":"Blood"},{"issue":"12","key":"62_CR27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.leukres.2004.04.016","volume":"28","author":"H Kojima","year":"2004","unstructured":"Kojima H, Hasegawa Y, Suzukawa K, et al.: Clinicopathological features and prognostic factors of Japanese patients with \u201cperipheral T-cell lymphoma, unspecified\u201d diagnosed according to the WHO classification. Leuk Res 2004, 28(12):1287\u20131292.","journal-title":"Leuk Res"},{"issue":"5","key":"62_CR28","first-page":"337","volume":"18","author":"S Caulet-Maugendre","year":"1996","unstructured":"Caulet-Maugendre S, Patey M, Granier E, et al.: Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin\u2019s lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions. Anal Quant Cytol Histol 1996, 18(5):337\u2013344.","journal-title":"Anal Quant Cytol Histol"},{"issue":"6","key":"62_CR29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V83.6.1460.1460","volume":"83","author":"TP Miller","year":"1994","unstructured":"Miller TP, Grogan TM, Dahlberg S, et al.: Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin\u2019s lymphomas: a prospective Southwest Oncology Group trial. Blood 1994, 83(6):1460\u20131466.","journal-title":"Blood"},{"issue":"1","key":"62_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2184.1997.tb00914.x","volume":"30","author":"C Mochen","year":"1997","unstructured":"Mochen C, Giardini R, Costa A, Silvestrini R: MIB-1 and S-phase cell fraction predict survival in non-Hodgkin\u2019s lymphomas. Cell Prolif 1997, 30(1):37\u201347.","journal-title":"Cell Prolif"},{"issue":"4","key":"62_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2559.1993.tb00128.x","volume":"22","author":"C Montalban","year":"1993","unstructured":"Montalban C, Obeso G, Gallego A, et al.: Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification. Histopathology 1993, 22(4):303\u2013310.","journal-title":"Histopathology"},{"issue":"3","key":"62_CR32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cncr.20341","volume":"102","author":"EV Sheval","year":"2004","unstructured":"Sheval EV, Churakova JV, Dudnik OA, Vorobjev IA: Examination of the proliferative activity of tumor cells in human lymphoid neoplasms using a morphometric approach. Cancer 2004, 102(3):174\u2013185.","journal-title":"Cancer"},{"issue":"1","key":"62_CR33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W, et al.: Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 2005, 131(1):29\u201338.","journal-title":"Br J Haematol"},{"issue":"4","key":"62_CR34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2559.2009.03250.x","volume":"54","author":"J Briones","year":"2009","unstructured":"Briones J, Moga E, Espinosa I, et al.: Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome. Histopathology 2009, 54(4):478\u2013485.","journal-title":"Histopathology"},{"issue":"15","key":"62_CR35","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/1078-0432.CCR-04-0269","volume":"10","author":"B Martinez-Delgado","year":"2004","unstructured":"Martinez-Delgado B, Melendez B, Cuadros M, et al.: Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 2004, 10(15):4971\u20134982.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"62_CR36","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","volume":"19","author":"B Martinez-Delgado","year":"2005","unstructured":"Martinez-Delgado B, Cuadros M, Honrado E, et al.: Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia 2005, 19(12):2254\u20132263.","journal-title":"Leukemia"},{"issue":"6","key":"62_CR37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(05)70213-8","volume":"6","author":"PP Piccaluga","year":"2005","unstructured":"Piccaluga PP, Agostinelli C, Zinzani PL, et al.: Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified. Lancet Oncol 2005, 6(6):440.","journal-title":"Lancet Oncol"},{"issue":"10","key":"62_CR38","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","volume":"25","author":"B Ballester","year":"2006","unstructured":"Ballester B, Ramuz O, Gisselbrecht C, et al.: Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006, 25(10):1560\u20131570.","journal-title":"Oncogene"},{"issue":"11","key":"62_CR39","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L Leval de","year":"2007","unstructured":"\u2022\u2022 de Leval L, Rickman DS, Thielen C, et al.: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007, 109(11):4952\u20134963. In this article, the authors provided molecular evidence that AITLs and some PTCLs\/NOS derive from follicular T-helper cells.","journal-title":"Blood"},{"issue":"22","key":"62_CR40","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"PP Piccaluga","year":"2007","unstructured":"\u2022\u2022 Piccaluga PP, Agostinelli C, Califano A, et al.: Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007, 67(22):10703\u201310710. In this article, the authors provided molecular evidence of AITL derivation from follicular T-helper cells and showed the aberrant expression of VEGF and VEGFR2 in such tumors.","journal-title":"Cancer Res"},{"issue":"4","key":"62_CR41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.10767","volume":"92","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Righi S, et al.: Expression of CD52 in peripheral T-cell lymphoma. Haematologica 2007, 92(4):566\u2013567.","journal-title":"Haematologica"},{"issue":"5","key":"62_CR42","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","volume":"109","author":"L Lamant","year":"2007","unstructured":"Lamant L, de Reynies A, Duplantier MM, et al.: Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood 2007, 109(5):2156\u20132164.","journal-title":"Blood"},{"issue":"22","key":"62_CR43","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","volume":"25","author":"M Cuadros","year":"2007","unstructured":"\u2022 Cuadros M, Dave SS, Jaffe ES, et al.: Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 2007, 25(22):3321\u20133329. In this article, the authors provided evidence of the prognostic relevance of proliferation rate in PTCL\/NOS, based on gene expression data.","journal-title":"J Clin Oncol"},{"issue":"5","key":"62_CR44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2008-07-166363","volume":"113","author":"K Miyazaki","year":"2009","unstructured":"Miyazaki K, Yamaguchi M, Imai H, et al.: Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma. Blood 2009, 113(5):1071\u20131074.","journal-title":"Blood"},{"issue":"17","key":"62_CR45","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2008-08-175901","volume":"113","author":"CA Pise-Masison","year":"2009","unstructured":"Pise-Masison CA, Radonovich M, Dohoney K, et al.: Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood 2009, 113(17):4016\u20134026.","journal-title":"Blood"},{"issue":"7","key":"62_CR46","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3324\/haematol.2009.006718","volume":"94","author":"A Gazzola","year":"2009","unstructured":"Gazzola A, Bertuzzi C, Agostinelli C, et al.: Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. Haematologica 2009, 94(7):1036\u20131037.","journal-title":"Haematologica"},{"issue":"6","key":"62_CR47","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, de Reynies A, de Leval L, et al.: Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal-type. Blood 2010, 115(6):1226\u20131237.","journal-title":"Blood"},{"key":"62_CR48","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"\u2022 Iqbal J, Weisenburger DD, Greiner TC, et al.: Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010, 115:919\u2013920. This large study basically confirmed previous data and supported the idea that PTCL\/NOS cases with different cellular derivation may have different clinical outcomes.","journal-title":"Blood"},{"issue":"9","key":"62_CR49","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2007-02-075036","volume":"110","author":"C Rodriguez-Antona","year":"2007","unstructured":"Rodriguez-Antona C, Leskela S, Zajac M, et al.: Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas. Blood 2007, 110(9):3345\u20133351.","journal-title":"Blood"},{"issue":"11","key":"62_CR50","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/jcp.2008.055335","volume":"61","author":"C Agostinelli","year":"2008","unstructured":"Agostinelli C, Piccaluga PP, Went P, et al.: Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. J Clin Pathol 2008, 61(11):1160\u20131167.","journal-title":"J Clin Pathol"},{"issue":"15","key":"62_CR51","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"\u2022\u2022 Lenz G, Staudt LM: Aggressive lymphomas. N Engl J Med 2010, 362(15):1417\u20131429. This is a comprehensive review on the molecular pathogenesis of aggressive B-NHL.","journal-title":"N Engl J Med"},{"issue":"7","key":"62_CR52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0046-8177(99)90147-8","volume":"30","author":"L Quintanilla-Martinez","year":"1999","unstructured":"Quintanilla-Martinez L, Franklin JL, Guerrero I, et al.: Histological and immunophenotypic profile of nasal NK\/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum Pathol 1999, 30(7):849\u2013855.","journal-title":"Hum Pathol"},{"issue":"3","key":"62_CR53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10245330400026162","volume":"10","author":"K Oshimi","year":"2005","unstructured":"Oshimi K, Kawa K, Nakamura S, et al.: NK-cell neoplasms in Japan. Hematology 2005, 10(3):237\u2013245.","journal-title":"Hematology"},{"issue":"4","key":"62_CR54","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, et al.: Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006, 24(4):612\u2013618.","journal-title":"J Clin Oncol"},{"issue":"1","key":"62_CR55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","volume":"15","author":"C Barrionuevo","year":"2007","unstructured":"Barrionuevo C, Zaharia M, Martinez MT, et al.: Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 2007, 15(1):38\u201344.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"62_CR56","first-page":"285","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"J Chan","year":"2008","unstructured":"Chan J, Quintanilla-Martinez L, Ferry J, Peh SC: Extranodal NK\/T-cell lymphoma, nasal-type. In WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, edn 4. Edited by Swerdlow S, Campo E, Harris NL, et al. Lyon: IARC; 2008:285."},{"issue":"17","key":"62_CR57","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"\u2022 Au WY, Weisenburger DD, Intragumtornchai T, et al.: Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009, 113(17):3931\u20133937. This large study within the International Peripheral T-Cell Lymphoma Project concerns nasal and extranasal NK\/T-cell lymphomas.","journal-title":"Blood"},{"issue":"4","key":"62_CR58","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2141.1997.1462962.x","volume":"97","author":"YL Kwong","year":"1997","unstructured":"Kwong YL, Chan AC, Liang R, et al.: CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997, 97(4):821\u2013829.","journal-title":"Br J Haematol"},{"key":"62_CR59","first-page":"77","volume":"3","author":"JK Chan","year":"1998","unstructured":"Chan JK: Natural killer cell neoplasms. Anat Pathol 1998, 3:77\u2013145.","journal-title":"Anat Pathol"},{"issue":"1","key":"62_CR60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","volume":"54","author":"MM Cheung","year":"2002","unstructured":"Cheung MM, Chan JK, Lau WH, et al.: Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002, 54(1):182\u2013190.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"62_CR61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/106689690401200410","volume":"12","author":"TT Kuo","year":"2004","unstructured":"Kuo TT, Shih LY, Tsang NM: Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol 2004, 12(4):375\u2013387.","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"62_CR62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, et al.: Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004, 104(1):243\u2013249.","journal-title":"Blood"},{"issue":"9","key":"62_CR63","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","volume":"17","author":"SB Ng","year":"2004","unstructured":"Ng SB, Lai KW, Murugaya S, et al.: Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004, 17(9):1097\u20131107.","journal-title":"Mod Pathol"},{"issue":"1","key":"62_CR64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Ma SY, Au WY, et al.: Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004, 103(1):216\u2013221.","journal-title":"Blood"},{"issue":"8","key":"62_CR65","first-page":"1063","volume":"90","author":"WT Huang","year":"2005","unstructured":"Huang WT, Chang KC, Huang GC, et al.: Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer\/T-cell lymphoma, nasal type. Haematologica 2005, 90(8):1063\u20131069.","journal-title":"Haematologica"},{"issue":"11","key":"62_CR66","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1158\/1078-0432.CCR-06-2373","volume":"13","author":"J Lee","year":"2007","unstructured":"Lee J, Suh C, Huh J, et al.: Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer\/T-cell lymphoma, nasal-type. Clin Cancer Res 2007, 13(11):3250\u20133254.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"62_CR67","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","volume":"21","author":"R Suzuki","year":"2010","unstructured":"Suzuki R, Suzumiya J, Yamaguchi M, et al.: Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol 2010, 21(5):1032\u20131040.","journal-title":"Ann Oncol"}],"updated-by":[{"DOI":"10.1007\/s11899-010-0066-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T00:00:00Z","timestamp":1285632000000}}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11899-010-0062-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T01:31:21Z","timestamp":1591752681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-010-0062-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,6]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s11899-010-0062-x","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,6]]}}}